NOVO.B.DK

239.15

-1.75%↓

GMAB.DK

1,837.5

-1.21%↓

HLUNB.DK

39.16

-0.66%↓

AMBUB.DK

78.3

-0.38%↓

NOVO.B.DK

239.15

-1.75%↓

GMAB.DK

1,837.5

-1.21%↓

HLUNB.DK

39.16

-0.66%↓

AMBUB.DK

78.3

-0.38%↓

NOVO.B.DK

239.15

-1.75%↓

GMAB.DK

1,837.5

-1.21%↓

HLUNB.DK

39.16

-0.66%↓

AMBUB.DK

78.3

-0.38%↓

NOVO.B.DK

239.15

-1.75%↓

GMAB.DK

1,837.5

-1.21%↓

HLUNB.DK

39.16

-0.66%↓

AMBUB.DK

78.3

-0.38%↓

NOVO.B.DK

239.15

-1.75%↓

GMAB.DK

1,837.5

-1.21%↓

HLUNB.DK

39.16

-0.66%↓

AMBUB.DK

78.3

-0.38%↓

Search

Coloplast A-S (Class B)

Închisă

482.4 -1.65

Rezumat

Modificarea prețului

24h

Curent

Minim

479

Maxim

490.5

Indicatori cheie

By Trading Economics

Venit

522M

1.4B

Vânzări

83M

7B

P/E

Medie Sector

27.754

110.024

EPS

6.32

Randament dividend

4.78

Marjă de profit

19.835

Angajați

16,983

EBITDA

309M

2.3B

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+11.86% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

4.78%

2.26%

Următoarele câștiguri

12 mai 2026

Data viitoare de dividende

20 mai 2026

Următoarea dată ex-dividende

18 mai 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-7.8B

111B

Deschiderea anterioară

484.05

Închiderea anterioară

482.4

Coloplast A-S (Class B) Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 feb. 2026, 23:07 UTC

Câștiguri

Woolworths 1st Half Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 feb. 2026, 23:01 UTC

Câștiguri

Fortescue 1st Half Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 feb. 2026, 22:59 UTC

Câștiguri

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability -- Update

24 feb. 2026, 22:42 UTC

Câștiguri

WiseTech to Cut 2,000 Jobs as It Asks AI to Boost Profitability

24 feb. 2026, 22:24 UTC

Achiziții, Fuziuni, Preluări

Warner Bros. Discovery Board Says Paramount Skydance's New Proposal Could Top Netflix Agreement -- Update

24 feb. 2026, 23:46 UTC

Market Talk

Gold Edges Higher Amid Possible Position Adjustments -- Market Talk

24 feb. 2026, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Rebound -- Market Talk

24 feb. 2026, 23:30 UTC

Market Talk

Fortescue's Copper Bet Is Long Term, While Iron Ore Remains Near-Term Driver -- Market Talk

24 feb. 2026, 23:20 UTC

Market Talk

Fortescue Dividend Beat Overshadows Profit Miss -- Market Talk

24 feb. 2026, 23:20 UTC

Market Talk

Global Equities Roundup: Market Talk

24 feb. 2026, 23:16 UTC

Câștiguri

Oversea-Chinese Banking Corp.'s CEO: "Looking Ahead, We Remain Cautious Yet Positive">O39.SG

24 feb. 2026, 23:13 UTC

Câștiguri

Oversea-Chinese Banking Corp. FY25 Non-Interest Income S$5.46B Vs. S$4.72B >O39.SG

24 feb. 2026, 23:12 UTC

Câștiguri

Oversea-Chinese Banking Corp.: FY25 Net Interest Income S$9.15B Vs. S$9.76B>O39.SG

24 feb. 2026, 23:10 UTC

Câștiguri

Oversea-Chinese Banking Corp. FY25 NPL Ratio 0.9%, Unchanged on Year>O39.SG

24 feb. 2026, 23:10 UTC

Câștiguri

Oversea-Chinese Banking Corp. FY25 Net Interest Margin 1.91%, Down 29bps on Year>O39.SG

24 feb. 2026, 23:08 UTC

Câștiguri

Oversea-Chinese Banking Corp. FY25 Net S$7.42B Vs. Net S$7.59B >O39.SG

24 feb. 2026, 23:07 UTC

Câștiguri

Oversea-Chinese Banking Corp. FY25 Total Income S$14.61B Vs. S$14.47B>O39.SG

24 feb. 2026, 22:52 UTC

Câștiguri

Woolworths 1H Profit Hit By Worker Pay Dispute, Still Boosts Dividend

24 feb. 2026, 22:46 UTC

Câștiguri

Fortescue 1H Net Profit, Dividend Rise on Higher Shipments, Prices -- Update

24 feb. 2026, 22:31 UTC

Achiziții, Fuziuni, Preluări

Warner Receives New Bid From Paramount -- 3rd Update

24 feb. 2026, 22:29 UTC

Câștiguri

Woolworths: FY Ebit Growth for Australian Food Expected at Upper End of Mid-to-High Single Digit Range Provided in August

24 feb. 2026, 22:28 UTC

Câștiguri

Woolworths: Australian Food Current Growth Rates Reflect Some Benefit from Cycling of Industrial Action Impacts

24 feb. 2026, 22:27 UTC

Câștiguri

Woolworths: Australian Food Sales +7.2% Excluding Tobacco in 2H First Seven Weeks

24 feb. 2026, 22:27 UTC

Câștiguri

Woolworths: Australian Food Sales +5.8% in 2H First Seven Weeks

24 feb. 2026, 22:25 UTC

Câștiguri

Woolworths: Customers Continue to be Value-Focused, Shopping Multiple Retailers in Highly Competitive Environment

24 feb. 2026, 22:24 UTC

Câștiguri

Woolworths: Trading in 3Q to Date Has Been Strong in Australian Food

24 feb. 2026, 22:23 UTC

Câștiguri

Woolworths 1H Group Sales A$37.1 Bln, Up 3.4%

24 feb. 2026, 22:22 UTC

Câștiguri

Woolworths Interim Dividend 45 Australian Cents/Share

24 feb. 2026, 22:22 UTC

Câștiguri

Woolworths 1H Profit Before Significant Items A$859 Mln, Up 16.4%

24 feb. 2026, 22:21 UTC

Câștiguri

Woolworths 1H Statutory Net Profit A$374 Mln, Down 49.4%

Comparație

Modificare preț

Coloplast A-S (Class B) Așteptări

Obiectiv de preț

By TipRanks

11.86% sus

Prognoză pe 12 luni

Medie 901.38 DKK  11.86%

Maxim 1,056 DKK

Minim 720 DKK

În baza a 8 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruColoplast A-S (Class B) - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

8 ratings

2

Cumpărare

4

Păstrare

2

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat